How fast do semaglutides work — and what should you realistically expect?

Step 1, the first four weeks: your body adjusting, not yet transforming

The first pen of semaglutide is dosed at 0.25mg. That is not a therapeutic amount chosen to produce dramatic weight loss; it is there to let your digestive system adapt gradually. GLP-1 medicines slow gastric emptying and act on hunger centres in the brain, and both effects can produce nausea if introduced too quickly. At this stage, many people notice their appetite feeling slightly different (meals feel more filling, snacking urges ease a little) but the scales may not move much. That is not failure. It is the medicine working exactly as designed.

A misconception worth gently letting go: a lot of people expect to feel noticeably lighter within days, and when they do not, they assume the medicine is not working for them. If you are wondering how fast semaglutide works and what the early weeks actually look like, it helps to understand that 0.25mg is a settling-in dose and the clinical effect builds as the dose increases over the coming months. Patience at this stage pays off.

Side effects, if they arrive, tend to be gastrointestinal, nausea, loose stools, some indigestion. These are usually mild and settle within the first couple of weeks. The NHS semaglutide medicines page lists what to expect and when to seek advice.

Step 2, weeks five to sixteen: the dose climbs, and so do the results

From 0.5mg, then 1.0mg, then 1.7mg, semaglutide's effect on appetite becomes more pronounced. This is typically when the scales begin moving more consistently. Hunger between meals decreases noticeably for many people; portion sizes naturally shrink; the pull toward high-calorie foods can ease. These are not willpower wins, they reflect measurable changes in hormone signalling that semaglutide triggers.

By around week 12, some people have lost five to ten percent of their starting body weight. Others are closer to three percent. Both are within the expected range at this stage. For a closer look at how quickly semaglutides work across different people, the titration schedule, individual metabolism and how closely lifestyle changes support the medicine all shape the pace. Our overview of semaglutide results at ten weeks covers what the evidence says about early progress.

It is also worth knowing that the dose increase schedule is guided by a prescriber, not self-directed. At nume, a clinician reviews your progress before any change, same-day, on working days.

Step 3, weeks seventeen to sixty-eight: the maintenance phase and peak results

The 2.4mg maintenance dose (or 7.2mg with the newly approved higher-dose pen) is where the largest and most consistent weight loss occurs. The STEP 1 trial ran for 68 weeks and found an average reduction of around 15% of body weight on 2.4mg semaglutide, a figure that reflects the cumulative effect of the full course, not a sudden drop. For context on what the newer 7.2mg dose adds, the page on Wegovy in the UK covers the approval and what it means.

Progress tends to follow a curve: faster in the early maintenance phase, then gradually slowing as the body reaches a new equilibrium. This is entirely normal and reflects how weight regulation works biologically. Reaching a plateau does not mean the medicine has stopped working; it may mean the dose needs reviewing with a prescriber, or that lifestyle factors need attention.

NICE guidance on semaglutide for weight management recommends reviewing whether to continue if weight loss is below 5% after six months at the maintenance dose. That review happens with a clinician, it is a clinical conversation, not an automatic stop. NICE TA875 sets out the full recommendation criteria.

What affects the pace, and what to do with that

Two people on identical doses can see quite different timelines. Starting body weight, age, baseline metabolic rate, how much nausea limits food intake early on, physical activity levels and the quality of dietary choices all play into the speed and scale of results. None of this is within the medicine's control; it is the reason semaglutide is described as a tool to support lifestyle change, not a replacement for it.

There are also practical factors. Missing doses, not increasing the dose on schedule, or stopping and restarting all affect the trajectory. For questions about managing any of those situations, our FAQs page covers common queries, and the clinical team at our support line is available seven days a week.

On cost, semaglutide is a private prescription medicine and the price varies by dose and provider. If you are weighing up the financial picture alongside the timeline of results, our Wegovy pricing page sets out what to expect and what a legitimate price should include. Speed of results is one thing; safe, clinically supervised supply is another, and the two belong together.

If you are ready to find out whether semaglutide is clinically suitable for you, start your free consultation with our GPhC-registered prescribers today.